Search - tctmd.com

Displaying 1 - 20 of 143

Sort: Relevancy | Date

News Opinion Editor's Corner

The Biggest News of 2022: TCTMD’s Top 10

Shelley Wood

December 30, 2022

News Opinion CV Team Dispatch

December 2022 News Roundup

L.A. McKeown

December 28, 2022

News Features

Heart Failure Care Has a Pipeline Problem: What’s the Fix?

Shelley Wood

December 20, 2022

News Daily News

FDA Advisors Recommend Against Approval of Omecamtiv Mecarbil

Michael O'Riordan

December 14, 2022

News Daily News

CVD Claimed 20 Million Lives in 2021, but Disease Burden Varies Globally

Michael O'Riordan

December 14, 2022

News Daily News

Cardiogenic Shock Outcomes Markedly Worse in De Novo HF Patients

Caitlin E. Cox

December 09, 2022

News Daily News

Query Use of Nontraditional Therapies for HF at Every Visit: AHA Statement

Todd Neale

December 09, 2022

News Daily News

Analysis Cements Benefits of SGLT2 Inhibitors in HF, but Diabetes Matters for Deaths

Michael O'Riordan

December 08, 2022

Will Tricuspid Innovation Outpace Mitral? Some Hopes, Some Second-Guessing

Shelley Wood

December 07, 2022

News Daily News

Meth-Related HF: Challenges at the Intersection of CVD and Addiction

Caitlin E. Cox

December 06, 2022

News Daily News

Myocarditis After COVID-19 Vaccination Less Serious Than Prepandemic Cases

Todd Neale

December 06, 2022

News Daily News

Impella RP Mortality Rate No Longer a Concern, FDA Says

Caitlin E. Cox

December 05, 2022

News Daily News

Motorcycle Rallies Bring More Organ Donors, Recipients

Yael L. Maxwell

December 01, 2022

News Daily News

Many ESC Guideline Recommendations Out of Reach in Poorer Regions

Michael O'Riordan

November 29, 2022

News Daily News

Exposure to Lead Linked to Risk of CVD Mortality: Strong Heart Study

Michael O'Riordan

November 18, 2022

News Conference News AHA 2022

Sizeable Minority of Pregnant Women Have CVD, US Data Show

Caitlin E. Cox

November 11, 2022

News Conference News AHA 2022

New Tool Assesses Risk in Acute HF Then Suggests Next Steps, Cutting Later Events

Yael L. Maxwell

November 07, 2022

News Conference News AHA 2022

Early ECMO No Better Than Watch-and-Wait Approach in Cardiogenic Shock

Caitlin E. Cox

November 06, 2022

News Conference News AHA 2022

TRANSFORM-HF: Torsemide No Better Than Furosemide for Hospitalized HF

Todd Neale

November 05, 2022

Advertisement

The Biggest News of 2022: TCTMD’s Top 10

December 2022 News Roundup

Heart Failure Care Has a Pipeline Problem: What’s the Fix?

FDA Advisors Recommend Against Approval of Omecamtiv Mecarbil

CVD Claimed 20 Million Lives in 2021, but Disease Burden Varies Globally

Cardiogenic Shock Outcomes Markedly Worse in De Novo HF Patients

Query Use of Nontraditional Therapies for HF at Every Visit: AHA Statement

Analysis Cements Benefits of SGLT2 Inhibitors in HF, but Diabetes Matters for Deaths

Will Tricuspid Innovation Outpace Mitral? Some Hopes, Some Second-Guessing

Meth-Related HF: Challenges at the Intersection of CVD and Addiction

Myocarditis After COVID-19 Vaccination Less Serious Than Prepandemic Cases

Impella RP Mortality Rate No Longer a Concern, FDA Says

Motorcycle Rallies Bring More Organ Donors, Recipients

Many ESC Guideline Recommendations Out of Reach in Poorer Regions

Exposure to Lead Linked to Risk of CVD Mortality: Strong Heart Study

Sizeable Minority of Pregnant Women Have CVD, US Data Show

New Tool Assesses Risk in Acute HF Then Suggests Next Steps, Cutting Later Events

Early ECMO No Better Than Watch-and-Wait Approach in Cardiogenic Shock

TRANSFORM-HF: Torsemide No Better Than Furosemide for Hospitalized HF

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content